Surgical Track e News April 2011

8/3/2019 Surgical Track e News April 2011

1/15

Version 09 April 2010_____________________________________________________________

1

2011 Europe an Multidisc iplina ry Canc er Cong ress: Deta iled Surgic a l Trac k

Saturda y 24 Sep temb er 2011

Speaker: R. Audisio (UK)

Speaker: T. Wiggers (NL)

Cha ir: M. Bauma nn (DE)

Chair: S. Go nzalez-Moreno (SP)

Peritonea l Ca rcinoma tosis of Colorecta l Origin

Spea ker: F. Quenet (FR)Peritoneal Mesothelioma

Spea ker: M. Deraco (IT)Pseudomyxoma Peritonei

Spea ker: S. Go nzalez-Moreno (SP)Discussion and Roundup

08:00-08:45 Teac hing Lecture

Breast Canc er in the Elde rly: Different Treatm ent Mo da lities


Mana gem ent of Loc al Rec urrenc e of Rec tal Canc er

13:45-15.45 Presidentia l Session I

Best and Late Break ing Abstrac ts

14:15-15:15 Spe c ial Session

Peritonea l Surfac e Onc olog y the Evide nc e for Loc oreg iona l Treatm ent



2/15

Version 09 April 2010_____________________________________________________________

2

Chair: A. Testori (Italy)

For Sentinel Node Positive Patients: Is Comp lete Lym ph Node Resectio n Still the Standa rd?

Spe ake r: O. Niewe g (The Ne the rland s)For Patien ts With Distant Meta stases: Surge ry Is First Cho ic e o f Trea tment

Spea ker: S. Schne eb aum (Israe l)

A Critica l View: Selec tion Is the Stand ard

Spe ake r: A.M.M. Egg ermont (The Nethe rlands)

Questions and Answers Including A udienc e a nd Final Vote to See if Aud ience Have Change dTheir Op inion

Cha ir: M. Wells (United Kingd om )

Improving the Diagnostic Pathway for Men With Prostate Cancer

Spe aker: M. Emb erton (United Kingd om )Robotic Surgery - Opp ortunities and Issues for Nursing

Spe ake r: S. Ma rtin (United Kingd om )Health-Related Quality of Life as a Prognostic Factor in Patients With Oesophageal Cancer

Spe ake r: P. Lag ergren (Swe de n)Discussion and Roundup

Cha ir: A. Kiltie (United Kingd om )

Update in Penile Cancer: Facts

Spe ake r: C. Meijer (The Nethe rlands)

SurgerySpea ker: E. Solsona (Spa in)Chemotherapy

Spea ker: M. De Santis (Austria)Discussion and Roundup

Too Little or Too Muc h Surge ry For Me lanom a


Developme nts in Surgical Onc ology


The Ma nage ment of Penile Canc er

14:45-16:45 Scie ntific Sympo sia


3/15

Version 09 April 2010_____________________________________________________________

3

Chair: U. Veronesi (Italy)

Co -Cha ir: L. Pierc e (USA)

Introduction

Spea ker: U. Veronesi (Ita ly)What Is the Role of Rad iotherapy in Red uc ing Loca l Rela pse Risk?

Speaker: L. Pierc e (USA)

What Are the Sourc es of Loc al Relapse?

Spea ker: M. Bollet (France)

What Are the Effects of Systemic Therap y in red ucing Loc al Relapse Risk?

Spea ker: S. Aeb i (Switzerland )

Should Women unde r 35 Years Be Treated b y Ma stec tom y?Spea ker: U. Veronesi (Ita ly)

Conclud ing Rema rks

Speaker: L. Pierc e (USA)

Chair: S.R.D. Johnston (United Kingdom)

The Role of Surgery in M etastatic Breast Canc erSpea ker: J. Ruiterkamp (The Nethe rland s)Rad iothera py in Patients With Meta static Breast Canc er

Spe aker: W. Buda ch (Germany)The Role o f Hormo nal Manip ulations in Patients With Hormone- Sensitive Meta static Breast Canc er

Spe ake r: M. Castiglione -Gertsch (Switzerland )The Role o f Chemothe rapy and Targe ted Ag ents in Patients With Meta static Breast Canc er

Spea ker: S.R.D. Johnston (United Kingd om )

Cha ir: C.J.H. van de Velde (The Ne therland s)

Conversion and Neoadjuvant Chemotherapy

Spe ake r: G. Folprec ht (Germa ny)Treatment o f PS2 and Rap idly Prog ressive Disease

Spe ake r: C. Verhoe f (The Nethe rlands)

The Trea tment o f Patie nts With Low Tumour Burde n and / or Slow Growing Disease

Spea ker: T.S. Ma ughan (United Kingd om )

Re-Cha llenge a nd the Conc ept of the Numb er Lines Therapy

Spe aker: A. de G ramont (France )

Breast Conservation in Young Women With Early Breast Canc er

16:00-18:00 Educational Symposium

Meta static Breast Canc er: What Do the Different Treatm ent Moda lities Add to Survival?

16:00-18:00 Educational Symposium

The Jungle of Treatments in Adva nce d Colorec tal Canc er


4/15

Version 09 April 2010_____________________________________________________________

4

Chair: D. De Ruysscher (The Netherlands)Co -Cha ir: P.A. Kosmid is (Switzerland )

Introduction

Spea ker: P.A. Kosmid is (Switzerland)Stag e III-N2 NSCLC: Ide ntifying Patients Subg roups and the Need to Tailor Therap y

Spea ker: K. O'Byrne (Irela nd )Evidenc e to Suppo rt Definitive Chem o-radiotherap y

Spea ker: D. De Ruysscher (The Netherland s)Evide nc e to Supp ort Use o f Planne d Surgery

Spea ker: P. De Leyn (Belg ium) Stag e III-N2 NSCLC: Choic e of Chem othe rapy Schem es

Spea ker: E. Felip Font (Spa in)Conclud ing Rema rks

Spea ker: D. De Ruysscher (The Netherland s)

Sund ay 25 Sep temb er 2011


Introduction

Spe aker: M. Baum ann (Germany)Quality Assurance of Oral Com plianc e

Spe ake r: K. Meier (Ge rmany)Quality Assuranc e o f Surgery

Spe ake r: C.J.H. van de Velde (The Net herland s)Quality Assurance of Radiotherapy

Spea ker: J. Bernier (Switzerland )


16:00-18:00 Scie ntific Sym posium

Optim al Treatm ent for a 72-ye ar Old Patient With Stag e III-N2 Non Sma ll Cell Lung Ca nc er

09:00-11:00 Sc ientific Sym po sium

Multidisciplinary Quality Assurance

11:30-12:15 Keynote Lecture


5/15

Version 09 April 2010_____________________________________________________________

5

Spe ake r: M. Stratto n (United Kingd om )

Chair: M. Baum ann (Germany)

Chair: T. Lehnert (DE)

How Rad ic al Should Surgery Be?

Spe ake r: C. Mariette (Franc e)Neoa djuv ant Treatm ent Better than Surgery Alo ne?

Spe ake r: T. Lehne rt (Ge rmany )Will Centralisation Imp rove Outc ome ?

Spe ake r: R.C. Ma son (United Kingd om )Discussion and Roundup

Chair: I.R.H.M. Koning s (The Net herland s)

Surgeon

Spe ake r: A. Mac iejewski (Poland )Clinica l Onco logist

Spea ker: S. Sleijfer (The Netherland s)Radia tion Onco logist

Spea ker: D. Zips (Ge rma ny)Discussion and Roundup

Do We Still Need to Understand the Ca nce r Genome ?

12:30-14:30 Presidentia l Session II

Pezco ller Found ation ECCO A ward Lec ture

Hamilton Fairley A ward Lec ture



Esopha gea l Canc er Ways to Improve O utcom e


Tips and Trick s to Be the Best

15:00-16:00 Debate

This House Believes That Surge ry Is The Ma instay fo r the Trea tment of PT2 Blad de r Canc er


6/15

Version 09 April 2010_____________________________________________________________

6

Mod erat or: J. Bellmunt (Spa in)

Surgery Is the Ma instay for the Treatm ent o f PT2 Blad de r Canc er

Spe ake r in Favour: M. Wirth (G erma ny)Surge ry Is NOT the Mainstay for the Trea tment o f PT2 Blad de r Canc er

Spea ker Ag a inst: A.L. Zietm an (USA)Surgery Is the Ma instay for the Treatm ent o f PT2 Blad de r Canc er

Sec ond er in Favour: A.R. Zlotta (Ca nada) Surge ry Is NOT the Mainstay for the Trea tment o f PT2 Blad de r Canc er

Sec ond er Against: A. Kiltie (United Kingd om )

Questions and Answers Including A udienc e a nd Final Vote to See if Aud ience Have Change d

Their Op inion

Cha ir: P. Nared i (Swe de n)

The ESSO Aw ard Presented to Ric ardo Aud isio

Awa rd Lec turer: R.A. Audisio (United Kingd om )Where and Why we Fail to Offer App ropriate Treatm ent to Old er Canc er Patients

Spea ker: M. Jansen-Heijnen (The Net herland s)Multimo da l Tailored Treatm ent to Older Rec tal Cance r Patients

Spea ker: H. Rutten (The Ne the rland s)

Canc er Clinic al Trials in the Elde rly: Are We Ag eist?Spe ake r: Malcolm Reed (UK)Gene ral Disc ussion

Spe ake r: R.A. Aud isio (United Kingd om )

Cha ir: M. Wirth (Ge rmany)

The Role of Scree ning in Prostate Canc er

Spea ker: F.H. Sc hrd er (The Netherland s)

Radic al Prostatec tomy - The Go ld Standa rd in the Treatment o f Loc alised and Loc ally Ad vanc ed

Prostate Cancer

Spe ake r: M. Wirth (Germa ny)

Cystecto my and Urinary Diversion - Lessons Lea rnedSpe ak er: H. van Pop pe l (Belg ium)

Trea tment o f Sma ll Renal Tumours, Surveilla nc e Foc al Trea tment o r Surge ry

Spe ake r: M. Marbe rger (Austria)

The EAU Guide lines on Testic ula r Canc er

Spe ake r: M.P. Laguna (The Nethe rlands)What Is New in the Systemic Treatm ent of Urologic al Ma lignanc ies

Spe ake r: P. Ab raha msson (Swe den)

16:45-18:15 ESSO Soc iety Session (Europe an Soc iety of Surgic al Onc olog y)

Tailored Treatm ent for Older Canc er Patien ts: A Multidisc iplina ry App roac h

16:45-18:15 EAU Society Session (European Association of Urology)

16:45-18:15 EANO Soc iety Session (Europe an Assoc iation of Neuro-Onc olog y


7/15

Version 09 April 2010_____________________________________________________________

7

Chair: W. Grisold (Austria)

The EANO Aw ard p resented to Kathy Oliver

New Entities in Parane op lastic Diseases

Spe aker: A. Vinc ent (United Kingd om )How to Improve the Extent o f Surgery With Better Neurologic al Func tion Preservation

Spea ker: L. Bello (Italy)Quality of Life and Cognitive Function Monitoring

Spea ker: M. Klein (The Ne the rland s)Stem Ce lls in Brain Tumours : Where Are We Going ?

Spea ker: R. De Maria (Italy)

Monday 26 Sep tem ber 2011

Spe ake r: A.D. Bailda m (United Kingd om )

Spe ake r: C.H. Bangm a (The Nethe rlands)

Cha ir: G. Giac c one (USA)

16:45-18:15 EUSOMA Society Session (European Society of Breast Cancer Specialists)

To be a nnounce d


Skin-Spa ring Mastec tom y


Ac tive Surveillance and Prostatec tomy

08:00-09:00 Interac tive Session With Patient C ases

Stag e IIIa Non-Sma ll Cell Lung Ca nc er Views by the Surgeon, Rad iotherap ist and M ed ic al

Oncologist


8/15

Version 09 April 2010_____________________________________________________________

8

Presentation o f a Com plex Case

Spe ake r: G. Giaccone (USA)Surgeon's Point of View

Spe aker: To Be Announc edRad iothe rapist's Point of View

Spe aker: To Be Announc ed

Medic al Onc ologist's Point of View

Spe aker: To Be Announc edDiscussion and Roundup

Cha ir: V. Valentini (Italy)

Co -Cha ir: L. Pahlman (Swe de n)

Introduction

Spe ake r: L. Ph lman (Swe den) Tailored Neoa djuv ant Therap y Ac co rding to Initial Stag ing Versus Biolog y Predic tors

Spea ker: K. Haustermans (Belg ium)

Tailored Therap y During Neo ad juvant Treatm ent

Spe ake r: V. Valentini (Ita ly)

Tailored Surgery Ac co rding to Clinica l Response

Spea ker: J.G. Guillem (USA)

Tailored Ad juvant Chem otherapy A cc ording to Pathologica l Response

Spea ker: W. Sche itha uer (Austria )Tailored Follow-Up Ac co rding to Stag ing

Spe ake r: L. Ph lman (Swe den)


Spe ake r: V. Valentini (Ita ly)

Cha ir: C. Faivre-Finn (United Kingd om )

Chair: E. Felip Font (Spa in)

Introduction

Spea ker: C. Fa ivre-Finn (United Kingdom )The Cha llenge of Assessing a nd Targe ting Tumo ur Hypoxia in Non-Sma ll Cell Lung Ca nce r

Speaker: Q. Le (USA)Intensity Mod ulated Rad iotherapy: Fixed -Beam a nd Arc Delivery Tec hnique s for Loc ally-

Adva nce d Disease

Spea ker: S. Senan (The Nethe rland s)Integrating Systemic and Rad iation Therapy in Loc ally A dva nce d Tumours

Spe ake r: A. Price (United Kingd om )Does Surgery Improve Outcom e?

Spea ker: U. Pastorino (Ita ly)


Tailored Neoad juvant Therapy in Rec tal Ca ncer


Non-Small Cell Lung Cancer Advance Disease


9/15

Version 09 April 2010_____________________________________________________________

9


Spea ker: E. Felip Font (Spa in)

Spe ake r: L. Ph lman (Swe den)

CCha ir: M. Baum ann (Germany)

Chair: J.P. Droz (Franc e)

Geriatric Evalua tion Is the Princip le Way of Assessing the Elde rly Patients

Spea ker: R. Berna bei (Italy)The Use of Sc reening Tools in Ge riatric Onco logy

Spea ker: M. Exterma nn (USA)Discussion and Roundup

Cha ir: R. Ada m (Franc e)

Surgical Resection of Hilar and Intrahem atic Cholangioc arcinom a

Spea ker: O. Farges (Franc e)

Liver Transplanta tion for Chola ngioca rcinom a

Spea ker: S. Jonas (Ge rmany)

11:30-12:15 Keynote Lecture

From Ca nce r Reg istries to Clinic al Prac tice

12:30-14.30 Presidentia l Session III


Polic y Mak ers Lec ture: To be a nnounc ed


Health Status in Sc reening in Elderly Patients Is This the Way Forward?


Managem ent of Hilar and Intrahepatic Choloangiocarcinoma


10/15

Version 09 April 2010_____________________________________________________________

10

Adjuva nt and Systemic Treatment of Advanc ed Cholang ioca rcinoma

Spe aker: J. Valle (United Kingd om )Discussion and Roundup

Chair: T. De Reijke (The Netherland s)

Active Surveillance

Spea ker: T. de Reijke (The Ne the rland s)Brac hytherapy - High Dose Rate or I-125?

Spea ker: P. Hoskin (United Kingdom )Heat, Ice and Light

Spe aker: M. Emb erton (United Kingd om )Discussion and Roundup

Chair: S. Bonvalot (France)

Differential Diag nosis of Retroperitonea l Sarc om a

Spe ake r: P.C.W. Hog end oo rn (The Nethe rlands)Surgical M anag eme nt of Prima ry Retroperitoneal Sarcom as: Imp roving Outco mes

Spea ker: D. Strauss (United Kingdom )

The Role o f Rad iotherap y in Retroperitonea l Sarc om a

Spea ker: F. Saran (United Kingdom )Discussion and Roundup

Cha ir: C.J.H. van de Velde (The Ne therland s)Co -Cha ir: A.F. Sob rero (Ita ly)

Introduction

Spea ker: A.F. Sob rero (Ita ly)The Co ntribution of Evidenc e Based Guidelines and Co mplianc e to Colon Ca ncer Survival

Spe ake r: G. Poston (United Kingd om )

Better Staging Leads to Better Survival in Colon Cancer; the Sentinel Node Reappraised

Spea ker: M. Zub er (Switzerland )


How Shou ld We Trea t Goo d Risk Prostate C ancer Foc ally or Entirely?


Mana gem ent of Retroperitoneal Sarcom a


Contributors to Better Survival in Colorectal Cancer


11/15

Version 09 April 2010_____________________________________________________________

11

Neoad juvant Treatment in Colon Canc erSpea ker: A.F. Sob rero (Ita ly)The Role of Rad iotherap y for Better Survival in Rec tal C anc erSpe ake r: C. Rd el (Germa ny)Making Non- Resectable Co lorectal Ca nce r Resectable

Spe aker: W. Hohenb erger (Ge rmany)Conclud ing Rema rksSpe aker: C.J.H. van d e Ve lde (The Net herland s)

Chair: P. Schffski (Belg ium)Co-Cha ir: K. Sund by Hall (Norway)

Introduction

Spea ker: P. Schffski (Belg ium) Inapprop riate Initial App roac hes to Soft-Tissue Sarc om a (Clinic al, Biopsy, Surgery, Ima ging )

Spe ake r: A. Hayes (United Kingd om )Soft-Tissue Sarc om a a s a Role M od el for Targe ted Treatm ent a nd Drug Develo pm ent

Spea ker: J.Y. Blay (France) Innova tive Rad iotherap y Ap proa c hes in Soft-Tissue Sarc om a

Spea ker: P. Sc a lliet (Belg ium) Who Need s a (New) Histopa thologic al and / or Molec ular Classifica tion?

Speaker: A.P. Dei Tos (Italy)

Conclud ing Rema rksSpea ker: K. Sund by Hall (Norway)

Mod erat or: B. Glimelius (Swe den)

TEM/ no Surgery Is Reliab le in Respond ers Rec tal Cance r Patients Afte r Preoperative

Chemoradiation

Spe ake r in Favo ur: C. Co co (Italy)TEM/ no Surge ry Is NOT Relia ble in Responders Rec ta l Canc er Patie nts Afte r Preope rative

Chemoradiation

Spe ake r Aga inst: C.J.H. van d e Ve lde (The Ne therland s)


New A venues in Soft- Tissue Sarc om a

17:00-18:00 Debate

This House Believ es That Transanal Endoscop ic Mic rosurgery (TEM)/ no Surgery Is Relia ble in

Responders Rectal Cancer Patients After Preoperative Chemoradiation


12/15

Version 09 April 2010_____________________________________________________________

12

TEM/ no Surgery Is Reliab le in Respond ers Rec tal Canc er Patients After Preop erative

Chemoradiation

Sec ond er in Favour: G. Lam me ring (The Ne therland s)

TEM/ no Surge ry Is NOT Relia ble in Responders Rec ta l Canc er Patie nts Afte r Preope rative

Chemoradiation

Sec ond er Aga inst: D. Seb ag-Mo ntefiore (United Kingdo m)

Questions and Answers Including A udienc e a nd Final Vote to See if Aud ience Have Change d

Their Op inion

Tuesday 27 September 2011

Spea ker: P. Willemsen (Belg ium)

Spe aker: J. Neopt olem os (United Kingdom )

Chair: F.H. Schroe der (The Ne the rland s)

Presentation o f a Com plex Case

Spea ker: F.H. Sc hroeder (The Ne the rland s)Urologist's Point of View

Spea ker: J. Hug osson (Swe den)Rad iothera pist's Point of View

Spe ake r: C. Parker (United Kingd om )Medic al Onc ologist's Point of View

Spe aker: To Be Announc ed


Overview on the Role of Lap arosco pic Surgery in Cance r Manag eme nt


Adjuva nt Treatment of Panc reatic Canc er

08:00-09:00 Interac tive Session With Patient C ases

A Patient w ith a T2N0M0 Prostate Canc er, Glea son Sc ore 7, Psa 19 g/ L Views by the Urologist,

Radio therapist and Me dica l Oncolog ist


13/15

Version 09 April 2010_____________________________________________________________

13

Discussion and Roundup

Cha ir: V. Greg oire (Belgium )Co-Cha ir: H. Lange nd ijk (The Nethe rlands)

Introduction

Spe ake r: H. Lange nd ijk (The Nethe rlands)Epide miolog y and the Practice of Treatment of the Elderly Patient in Head a nd Nec k Ca nce rSpea ker: K. Syrigos (Greec e)Spe cia l Considerations in Surgery for Elde rly Patients With Head a nd Nec k Ca nc erSpea ker: J.L. Lefe bvre (Franc e)Lac k o f Bene fit of Intensified Treatm ent Strateg ies in Elde rly Patients With Squa mo us Cell Head and

Neck Cancer

Spea ker: L. Licitra (Italy)The Impo rtanc e o f Geriatric Assessme nt Using the Frailty Index a mo ng Patients With Head and

Nec k Canc er Treated With Rad iotherapy : Toxic ity and Quality o f LifeSpe ake r: H. Lange nd ijk (The Nethe rlands)Conclud ing Rema rks

Spe ake r: V. Grego ire (Belgium)

Cha ir: D. Ga brys (Poland )

Co-Chair: E. Martinelli (Italy)

Introduction

Spe ake r: D. Gabrys (Polan d)Early and Late Side Effects Related to Surgery

Spe ake r: C. Verhoe f (The Nethe rlands)Comb ination of Radiotherap y a nd Targeted Agents: What Should We Expec t?

Spe ake r: M. Brad a (United Kingdo m)

Is It Time to Review the Com mune Toxic ity Criteria in the Era of New Targe ted Drugs?Spea ker: J. Jassem (Pola nd )How to Follow Up the A cute and the Late Toxic ity With New Eme rging Therap ies?

Spea ker: Z. Liao (USA)Conclud ing Rema rks

Spea ker: E. Ma rtinelli (Ita ly)


Head and Neck Canc er in the Elderly Patient


Mana ging the Side Effects


Hep atoc ellular Carninoma : Novel Ad vanc em ents in Diagnosis and Treatment


14/15

Version 09 April 2010_____________________________________________________________

14

Chair: J. Llovet (Spain)

Cha ir: V. Ma zzafe rro (Ita ly)

Introduction

Spea ker: V. Mazzaferro (Italy)

New Molec ular Targe ted Therap ies

Spea ker: J. Llove t (Spain)Novel Imaging Tec hniques and Treatm ent A ssessme nt for Evalua ting Benefit From Targe ted

Agents

Spe ake r: V. Vilgrain (Franc e)

Loc al Therapy fo r HCC

Spea ker: E. Lartiga u (Franc e)

Liver Transplanta tion and Resectio n for HCC

Spea ker: V. Mazzaferro (Italy)

Conclud ing Rema rksSpea ker: J. Llove t (Spain)


Chair: M. Leidenius (Finland)

Surge ry of the Primary Tumour

Spea ker: G. Vlastos (Switzerland )Surgery o f Liver and Pulmonary M etastases

Spe ake r: R. Ada m (Franc e)Disc ussion and Round up

09:00-11.00 Presidentia l Session IV

Best and Late Break ing Abstrac tsPolicy Make rs to Be Announc ed


Surgica l Treatm ent in Breast Ca nc er Patients With Distant Meta stases


Is the Biolog y of of Meta static Breast Canc er Simila r to thePrimary Breast Canc er?


15/15

Version 09 April 2010_____________________________________________________________

15

Chair: I. Smith (United Kingdom )

Rec ep tors and Her2 to New Status Primary to Meta static Intra Patients Differenc e?

Spe ake r: G. Via le (Italy)Genom ic Data o n Metastatic Disease

Spe ake r: C. Klein (Germany )Should Biopsy Be Done in Each Patient With a Suspicion of Metastatic Relapse?

Spe ake r: J. Bergh (Swe de n)Discussion and Roundup

Cha ir: P. Darteve lle (France)

Alternative Surgical Resections for Lobectomy Spe ake r: P. Darteve lle (Franc e)Role of Stereota ctic Rad iotherapy Spe aker: M. Guc kenbe rger (Germany)Role of Radio-Frequency AblationSpe ake r: T. de Bae re (Franc e)Discussion and Roundup

Chair: S. Sub ram anian (Russian Fed eration )

Biological Insights

Spe ake r: R. Co pp es (The Nethe rlands)

Late Functional Outc ome in Chemo- Rad iation

Spe ake r: H. Lange nd ijk (The Nethe rlands)Late Functional Outcome Surgery

Spe ake r: A. Dietz (Germany)

Discussion and Roundup


Treatm net o f T1N0M0 NSCLC in Patients Who Are Not Ca ndid ates for Lob ec tom y


Late Toxicity Treatment o f Head and Neck Canc er

Documents

Surgical Track e News April 2011